Caribou Biosciences has launched a Phase 1 trial testing its CAR T-cell therapy CB-010 for lupus affecting the kidneys and ...
Using glucocorticoids, rituzimab, or certain immunosuppressants to treat connective tissue diseases is associated with ...
People with lupus-related skin problems are more likely to develop heart disease associated with hardening of the a ...
You might associate autoimmune conditions with symptoms like skin disease, chronic pain, and fatigue. A less-discussed ...
The Phase 1 GALLOP study evaluating the investigational therapy, CB-010, for treatment of lupus nephritis has launched.